Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection
about
Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureusPharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infectionWhat do we really know about antibiotic pharmacodynamics?In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection.Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.The interaction of mannose binding lectin (MBL) with mannose containing glycopeptides and the resultant potential impact on invasive fungal infection.Vancomycin therapeutic drug monitoring: is it necessary?In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidisAnalysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic responseComparison of the antibacterial effects of cefepime and ceftazidime against Escherichia coli in vitro and in vivo.Population pharmacokinetic parameters of vancomycin in critically ill patients.Pharmacokinetics of vancomycin during continuous hemodiafiltration.Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection.Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.Levels of vancomycin in the cerebral interstitial fluid after severe head injury.Clinical Pharmacokinetics and Pharmacodynamics of Telavancin Compared with the Other Glycopeptides.Pharmacokinetic-pharmacodynamic model for spiramycin in staphylococcal mastitis.
P2860
Q33756241-94A0CBA3-4F73-47AD-B12D-DEB58BA5FF1CQ33979426-9EAC1564-BB3D-4986-A6DD-75F74D4E1173Q34443407-AAA5987E-4C4B-4D26-B08B-44F49F9328F2Q35129412-333F2073-C85F-4B2F-9DDE-F9704DFF2295Q35138007-256C4634-F3F0-400A-9C00-E9F9D8E3D57BQ35138366-8C0BB69C-2199-4F76-B4C9-21B102E3F7B7Q37625071-406BD77A-36B3-4A97-96B2-40E2498151C5Q38356990-9295CF12-E469-4D19-BA8E-D35AAB515C3BQ38566835-2F3E25A0-52A1-4D91-ABFF-7629A493B1BEQ39559251-A8450F76-CFED-4428-9D6C-07842D037E19Q39881225-3ECE6B91-F4EE-4561-BBAB-CEA485BC4ACFQ40284499-9D7FDC44-8728-4935-A1F6-A25111DD6381Q40290397-CC02E088-A876-4413-99E2-C4EC4ABD7C22Q42608683-AFD49941-E6F7-4378-8745-60DB55054F4FQ43233889-4603D62F-EB5F-4C4D-9D76-E72A1366E028Q45933494-DE1CAB3A-2442-44FB-A954-FCE1839D27EDQ46908278-6B675602-B7F5-4DA9-A14F-49823DFF38D8Q50053159-BEA00F58-1EFE-4105-A45C-F4CEF444319CQ52307488-A80D0EB7-F162-4122-9458-A69C63147EE2
P2860
Antistaphylococcal activities of teicoplanin and vancomycin in vitro and in an experimental infection
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Antistaphylococcal activities ...... d in an experimental infection
@en
Antistaphylococcal activities ...... in an experimental infection.
@nl
type
label
Antistaphylococcal activities ...... d in an experimental infection
@en
Antistaphylococcal activities ...... in an experimental infection.
@nl
prefLabel
Antistaphylococcal activities ...... d in an experimental infection
@en
Antistaphylococcal activities ...... in an experimental infection.
@nl
P2093
P2860
P356
P1476
Antistaphylococcal activities ...... d in an experimental infection
@en
P2093
Hazekamp-van Dokkum AM
Hoogeterp JJ
Peetermans WE
van den Broek P
P2860
P304
P356
10.1128/AAC.34.10.1869
P407
P577
1990-10-01T00:00:00Z